COVID-19 Claims for OTC Intravenous Drips Found In Advertising On Both Sides Of Atlantic
UK agency advises two medical spas to discontinue claims suggesting IV drips prevent or cure COVID-19. In separate rulings to the companies, ASA notes the UK MHRA says including COVID-19 in promotions would bring the IV drips under medicines regulation.
You may also be interested in...
Marketer of Billy’s Infinity-C supplement line discontinues social media post that COVID-19 patients in hospitals are receiving high doses of vitamin C. BBB National Programs division says the post implies consumers can prevent contracting the virus through vitamin C use.
Dietary supplement ads should not make any explicit or implicit references to COVID-19, with immunity boosting claims also strictly off limits, says UK regulator the Advertising Standards Authority.
Variety of products advertised with false coronavirus claims also grew in FTC's latest warnings submitted. It warned 21 firms on claims for products including IV drips, ozone therapy and stem cell treatments.